Vida More than Triples Assets Under Management in Less than Two Years to Approximately $1 Billion Based on Success of Inaugural Fund and Focus on Funding Transformational Science
Team Expands Business, Scientific and Clinical Expertise with the Additions of Helen S. Kim, Rajul Jain, M.D., Heba Nowyhed, Ph.D. and Eric Trac, M.D. BOSTON, August 1, 2019-- Vida Ventures (“Vida”), a next-generation life sciences venture firm, announced today the closing of Vida Ventures II, LLC (“Vida II”), raising $600 million in an oversubscribed fund.